Stay updated on SafetyEfficacy MAGE-A3/A6 TCR T Cells in HLA-DPB1*04:01 Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy MAGE-A3/A6 TCR T Cells in HLA-DPB1*04:01 Clinical Trial page.

Latest updates to the SafetyEfficacy MAGE-A3/A6 TCR T Cells in HLA-DPB1*04:01 Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.4.3 was added to the record history and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, and older notices (including the lapse in government funding and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a government funding notice and the latest site revision tag (v3.4.1); removed the previous revision tag (v3.4.0).SummaryDifference0.5%

- Check48 days agoChange DetectedUI/text changes clarify how revisions are displayed, including showing the glossary, color-coded diffs, and the Revision: v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check62 days agoChange DetectedThe page history now shows the addition of revision v3.3.4 and the removal of v3.3.3, with no core content or study data affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter updates: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SafetyEfficacy MAGE-A3/A6 TCR T Cells in HLA-DPB1*04:01 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy MAGE-A3/A6 TCR T Cells in HLA-DPB1*04:01 Clinical Trial page.